Euro-Med Laboratories Phil., Inc. Sustainability Profile
Euro-Med Laboratories Phil., Inc., commonly referred to as Euro-Med, is a leading player in the pharmaceutical and healthcare industry, headquartered in the Philippines. Established in 1992, the company has made significant strides in providing high-quality medical products and services across the Asia-Pacific region. Specialising in the distribution of pharmaceuticals, medical devices, and diagnostic products, Euro-Med is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of healthcare solutions that cater to the evolving needs of healthcare professionals and patients alike. With a strong market presence, Euro-Med has achieved notable milestones, including partnerships with renowned global manufacturers. This positions the company as a trusted provider in the healthcare sector, dedicated to enhancing patient care through reliable and effective medical solutions.
DitchCarbon Score
How does Euro-Med Laboratories Phil., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Euro-Med Laboratories Phil., Inc.'s score of 21 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Euro-Med Laboratories Phil., Inc.'s reported carbon emissions
In 2023, Euro-Med Laboratories Phil., Inc. reported total carbon emissions of approximately 20,640,210 kg CO2e, comprising 7,803,600 kg CO2e from Scope 1 and 12,578,610 kg CO2e from Scope 2 emissions. This reflects a slight decrease from 2022, where emissions were about 19,763,000 kg CO2e, with Scope 1 at 7,932,000 kg CO2e and Scope 2 at 11,643,000 kg CO2e. In 2021, the company recorded total emissions of approximately 16,688,177 kg CO2e, with Scope 1 emissions at 5,719,205 kg CO2e and Scope 2 at 10,889,972 kg CO2e. Despite these figures, Euro-Med Laboratories Phil., Inc. has not set specific reduction targets or initiatives as part of their climate commitments. The company operates as a current subsidiary and reports emissions data directly, without cascading from a parent organisation. Their emissions data is sourced from their own sustainability reports, reflecting their commitment to transparency in environmental impact reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 5,719,205 | 0,000,000 | 0,000,000 |
| Scope 2 | 10,889,972 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Euro-Med Laboratories Phil., Inc.'s Industry?
How Carbon Intensive is Euro-Med Laboratories Phil., Inc.'s Location?
Euro-Med Laboratories Phil., Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Euro-Med Laboratories Phil., Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
